Research Paper Volume 16, Issue 5 pp 4423—4444
SLC20A1 is a prospective prognostic and therapy response predictive biomarker in head and neck squamous cell carcinoma
Figure 1. Exaggerated SLC20A1 expression levels in HNSCC. (A, B) SLC20A1 mRNA expression between the HNSCC specimens and nearby sound tissues from TCGA database and qRT-PCR analysis. (C) SLC20A1 protein expression in the HNSCC specimens and nearby sound ones from Western blotting analysis. (D) DNA methylation modification associated with SLC20A1 expression in HNSCC. *, P<0.05.